Next Article in Journal
Curcumin Attenuates the Pathogenicity of Entamoeba histolytica by Regulating the Expression of Virulence Factors in an Ex-Vivo Model Infection
Previous Article in Journal
Molecular Epizootiology of Toxoplasma gondii and Cryptosporidium parvum in the Eastern Oyster (Crassostrea virginica) from Maine (USA)
 
 
Review
Peer-Review Record

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

Pathogens 2019, 8(3), 126; https://doi.org/10.3390/pathogens8030126
by Israr Khan 1,2,3, Naeem Ullah 1,2,3, Lajia Zha 1,2,3, Yanrui Bai 1,2,3, Ashiq Khan 1,4, Tang Zhao 1,2,3, Tuanjie Che 5 and Chunjiang Zhang 1,2,3,5,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pathogens 2019, 8(3), 126; https://doi.org/10.3390/pathogens8030126
Submission received: 5 July 2019 / Revised: 3 August 2019 / Accepted: 5 August 2019 / Published: 13 August 2019

Round 1

Reviewer 1 Report

Khan et al. nicely revised the current status of IBD studies in the context of microbiota and therapeutic approaches. The context is well designed and subsections of manuscript describe each context adequately. One important thing that is missing is the studies from 2019. There are at least two critical studies that are summarizing most of the microbiota profile that they mentioned in this review. Therefore, I'd like to ask author kindly to check the further literature from 2019 and add at least these two critical manuscripts into their review. These manuscripts provides intellectual inputs for their review.


1 -https://www.nature.com/articles/s41591-018-0308-z

2 - https://www.nature.com/articles/s41586-019-1237-9


Besides that, there are numerous typos in the manuscript. It is important that authors go through the text carefully and revise the manuscript.


Some of those typos and sentences that need to be corrected are as the following:



- There are some bold sentences or group of words should be converted non-bold state.

- Figures' quality are relatively bad and authors should provide a better resolution.


Line 34 - "modles" should be "models"

Line 35 - 37 - Sentence needs to be revised. Grammatically wrong.

Line 38 - Less and conflicting results? Not clear!

Line 48 - Chron’s disease need to be corrected into Crohn’s disease

Line  113 - (SCFAs) is already introduced in Line 86. No need to repeat the meaning of abbreviation.

Line 120 - 124 - The authors show the microbial differences in IBD patients compared to control but they should also mentioned differences between CD vs Control or UC vs Control.

Line 186-202 - species is missing "s" at the end.

Line 192 - enterobacteriacae should be Enterobacteriacae

Line 231 - 234 - The sentence needs to be revised. It is repetative of the same statement.

Line 234 - "Needs" to be

Line  271 - in to should be "into"

Line 285 - sub sets should be subsets 

First letter of Enterobacteriacae and Bifidobacteria should be capitalized. It was observed in couple of places that this is not the case.


Author Response

Please, find a point-by-point response to the reviewer-1 report , as an attachment named Response to reviewer-1.

Author Response File: Author Response.docx

Reviewer 2 Report

This review article is scientifically designed, and the presentation is also overall and elaborated form data collection to literature review, making the conclusion very convincing.The topic of the paper is very relevant. However, some minor revisions are needed.


Manuscript revision

Line 25. Replace Crohon’s with Crohn’s

 

Line 26. Review the grammatical in “Although the etiology of IBD is unknown, however the gut microbiota alteration 26 (dysibiosis) considered as a novel factor to be involved in IBD pathogenesis”.

 

Line 38

Replace Less with less

 

Line 66

Replace [18, 19]  with [18,19] 

 

Lines 117 and 204

Replace etio-pathology with etiopathology

 

Line 127

Replace [28,84, 85] with [28,84,85]

 

Line 129

Relocate [88, 89]

 

Line 136

Replace entero-pathy with enteropathy

 

Lines 168 and 171

Replace pre-biotics with prebiotics

 

Line 204

Replace etio-pathogenesis with etiopathogenesis

 

Line 511

In the Conclusion section, the wording should be improved

 

Line 536

Replace necessary with necessary.

 

Line 553

Replace colleague with colleagues.

 

Line 564

Replace “Nature reviews Gastroenterology & hepatology” with “Nature Reviews Gastroenterology & Hepatology”

 

Line 567

Replace “The American journal of gastroenterology” with “The American Journal of Gastroenterology”. There are similar problems in other references.

 

Line 568

Replace 647 with 647-654

 

Line 585

Replace 13 with 13-27

 

Line 592

Replace 41 with 41-50

 

Line 594

Replace 64 with 64-69

 

Line 610

Replace 3 with 3-4

 

Line 615

Replace 185 with 185-210

 

Line 617

Replace “A human gut microbial gene catalogue established by metagenomic sequencing. nature, 464(7285), 59” with “A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59-65”

 

Line 633

Replace “Sci Trans Med 1, 614” with “Sci Trans Med 1(6), 6-14”

 

Line 640

Replace 69 with 69-75

 

Line 642

Delete 33 at the end of the line

 

Line 644

Replace 85 with 85-93

 

Line 649

Replace 451 with 451-455

 

Line 651

Replace 159 with 159-169

 

Line 677

Replace 573 with 573-584

 

Line 689

Replace 18 with 18-26

 

Line 695

Replace 577 with 577-591

 

Line 706

Replace 691 with 691-701

 

Line 711

Replace 321 with 321-325

 

Line 713

Replace 541 with 541-546

 

Line 716

Delete 52 at the end of the line

 

Line 717

Replace 800 with 800-812

 

Line 754

Replace 2143-5 with 2143-2145

 

Line 789

Replace 2219 with 2219-2241

 

Line 794

Replace

Matsuoka, K., & Kanai, T. (2015, January). The gut microbiota and inflammatory bowel disease. In Seminars in immunopathology (Vol. 37, No. 1, pp. 47-55). Springer Berlin Heidelberg

with

Matsuoka, K., Kanai, T. (2015). The gut microbiota and inflammatory bowel disease. In Seminars in Immunopathology, 37(1), 47-55

 

Line 848

Replace 564 with 564-567

 

Line 854

Replace 1192 with 1192-1210

 

Line 883

Replace 295 with 295–306

 

Line 901

Replace 4892 with 4892–4904

 

Line 925

Replace 1259 with 1259–1267

 

Line 984

Replace 2619 with 2619–2629

 

Line 987

Replace 1403 with 1403-1417

 

 

Line 1000

Replace 119 with 119-124

 

Line 1006

Replace 710 with 710-712

 

Line 1009

Replace 599 with 599-603

 

Line 1011

Replace 603 with 603-606

 

Line 1019

Replace 800 with 800-809

 

Line 1034

Replace 123(2) with 123(2), 700-711

 

Line 1037

Replace 207 with 207-211

 

Line 1042

Replace 259 with 259-263

 

Line 1044

Replace 335 with 335-339

 

Line 1045

Replace

Ward, J. M., Anver, M. R., Haines, D. C., Melhorn, J. M., Gorelick, P., Yan, L., & Fox, J. G. (1996). Imflammatory large bowel disease in immunodeficient mice naturally infected with. Helicobacter hepaticus. Lab. Anim. Sci, 46, 15.

With

Ward, J. M., Anver, M. R., Haines, D. C., Melhorn, J. M., Gorelick, P., Yan, L., & Fox, J. G. (1996). Imflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci, 46(1), 15-20.

 

Line 1056

Replace 557 with 557-561

 

Line 1070

Replace 1563 with 1563-1568

 

Line 1206

Replace 2218 with 2218-2227

 

Line 1257

Replace 1620 with 1620-1630

 

Line 1263

Replace 5359 with 5359-5371


Author Response

Please, find a point-by-point response to the reviewer-2 report , as an attachment named Response to reviewer-2.

Author Response File: Author Response.docx

Back to TopTop